Church & Dwight Company, Inc. (CHD) Stock Price & How to Invest

Church & Dwight is an American consumer packaged goods company headquartered in Ewing, New Jersey, that makes household, personal-care and specialty products. It sells more than 80 brands, but roughly a dozen "power brands" (Arm & Hammer, OxiClean, Trojan, Nair, First Response, Orajel, Batiste, Waterpik, TheraBreath, Hero Cosmetics and others) drive the bulk of revenue. The mix blends slow-and-steady staples like baking soda and laundry additives with faster-growing personal-care acquisitions, and the company has a long track record of bolt-on M&A and consistent dividend increases.

The investment picture is that of a defensive compounder. CHD posts modest but reliable organic growth, expanding gross margins from productivity programs, and strong free cash flow, which supports buybacks and a multi-decade dividend history. The tension is valuation: the stock trades around 30x earnings, a premium to the household-products group, at a time when U.S. organic growth has been soft and the 2026 plan leans on new-product launches and back-half execution. Bulls point to margin gains and the personal-care pivot, while skeptics see a stretched multiple against muted domestic demand and heavy competition from far larger rivals.

U.S. organic growth has been soft, with some domestic categories declining, so 2026 guidance is back-half weighted and carries execution risk on new-product launches. At around 30x trailing earnings, the valuation is a premium to the household-products group and leaves little margin for error if volumes or margins disappoint. The company competes with far larger rivals such as Procter & Gamble and Colgate-Palmolive that have bigger marketing budgets and shelf presence. Input-cost inflation, tariffs and private-label competition can pressure margins, and CHD faces routine product-related consumer litigation typical of large CPG companies. A separate SEC proxy-disclosure matter involving a former CEO was settled in 2024 and is not an active securities-fraud case.

19 analysts publish price targets on CHD, averaging $105.37 against a $99.43 price as of September 2026, or +6.0%. The published targets run from $78.00 to $115.00, a moderate spread, and the ratings split 10 buy, 9 hold, 2 sell. Over the last six months there have been 11 raises and 0 cuts among the published actions. A price target is what an analyst published on a date, not a prediction, and sell-side ratings skew positive across the whole market.

Read the full CHD forecast and price target for the target table, the recent rating actions by firm, and how the consensus has shifted.

We give no verdict on Church & Dwight Company, Inc.. Both cases are real, which is why the question is contested at all, so here is the strongest version of each.

The case for buying. Power-brand and personal-care mix. A concentrated set of power brands (Arm & Hammer, OxiClean, Trojan, Batiste, TheraBreath, Waterpik, Hero Cosmetics) generates most of the revenue, and the faster-growing personal-care names give CHD a higher-growth tilt than a pure household-products company. The most optimistic published target, $115.00, assumes this works close to its best case.

The case against. U.S. The most pessimistic target, $78.00, is roughly what CHD is worth if this bites instead.

Read the full bull and bear case on CHD, including what would have to change to break either one. Walnut is not an investment adviser.

Yes. Church & Dwight Company, Inc. (CHD) has had one share split in the last 10 years:

• 2:1 on September 2, 2016, so every share held became 2 shares.

A split changes the share count and the price per share and leaves the value of a holding unchanged. Someone holding $1,000 of CHD the day before the 2:1 split held $1,000 the day after, in more shares at a proportionally lower price. Historical prices from before the date are normally shown split-adjusted, which is why a long-run chart shows no cliff.

Splits matter mainly because they make older price figures confusing to compare by hand, and because a board choosing to split is usually signalling that the price has run up far enough to feel awkward for smaller buyers. Neither is a reason to buy or sell.

A simple financial snapshot. These are approximations and refresh quarterly; for current figures see Church & Dwight Company, Inc.'s investor relations page or your broker.

• Revenue (TTM): ~$6.2B
• Market cap: ~$23B
• P/E (TTM): ~32x
• EPS (TTM): ~$3.04
• Dividend yield: ~1.3%
• 2026 FCF guide: ~$1.15B

Q1 2026 net sales were about $1.47 billion (up 0.2%), with organic sales up 5.0% and adjusted EPS of $0.95, both ahead of the company outlook. Management targets roughly 3% to 4% organic growth and 5% to 8% adjusted EPS growth for 2026. The premium multiple reflects CHD's defensive profile and margin expansion, but it also assumes steady execution against soft domestic demand.

Other names that sit close to CHD: same theme, named as a direct competitor, or held beside it in the same funds. Each entry says which. Worth a look if you are thinking about diversification within a thesis rather than concentration on one ticker.

There are three common ways to get CHD exposure. Buy shares (or fractional shares) directly at any major broker. Hold an ETF that includes it, which spreads the position across many companies. Or build it into a focused thematic portfolio, so CHD sits alongside other stocks that express the same thesis.

Walnut takes the portfolio route. Describe a thesis where CHD fits (for example “AI infrastructure” or “dividend-growth large-caps”) and the AI proposes 5 to 6 constituents with target weights. You review the plan and fund it through your own broker when you're ready.

New to this? Start with how to invest in stocks, see how to analyze a stock with AI, or compare the best AI stock analyzers.

CHD is a well-run, defensive staples name valued at a premium, so the debate is about paying up for consistency versus the drag from soft U.S. organic growth.

Whether CHD is worth buying today depends more on your time horizon and what you already hold than on any single call. We walk through valuation, what would have to go right, and the risks in is CHD a buy or a sell?, and where the stock could go from here in the CHD stock forecast.

For income investors, whether CHD pays a dividend and how the payout looks is covered in does CHD pay a dividend? And to weigh CHD against a peer, read the full side-by-side comparisons: CHD vs PG and CHD vs CL.